Troleandomycin
- TRADE NAME: TAO (Pfizer)
- INDICATIONS: Various infections caused by susceptible organisms
- CLASS: Antibiotic, macrolide
- HALF-LIFE: N/A
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Aprepitant, Astemizole, Carbamazepine, Colchicine, Crizotinib, Cyclosporine, Dihydroergotamine, Dutasteride, Ergot alkaloids, Ergotamine, Erlotinib, Erythromycin, Fluoxetine, Fluvoxamine, Methylergonovine, Methylprednisolone, Methysergide, Oral contraceptives, Paroxetine, Pimozide, Prednisolone, Rifampin, Rilpivirine, Sertraline, Solifenacin, Terfenadine, Warfarin
Please login to see the rest of this drug profile
SKIN
MUCOSAL
CARDIOVASCULAR
NEUROMUSCULAR/SKELETAL
GASTROINTESTINAL/HEPATIC
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life Threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric